Subtle Medical, a global leader in AI-powered medical imaging software, announced the commercial availability of SubtleHD in Chile, marking an important step in expanding access to advanced imaging solutions across Latin America. The company also confirmed it will partner with Hospiline, a trusted regional distributor that currently supports Subtle Medical’s growth in Brazil.
Health Technology Insights: Minset Raises Funds to Scale AI for $400 Billion Healthcare Revenue Cycle
SubtleHD is an FDA-cleared and CE-marked deep learning technology that transforms the quality of MRI images and enables up to 80% time savings on some sequences. It integrates seamlessly into existing clinical workflows, extending the life and performance of existing MRI scanners, an especially critical need across Latin America, where aging imaging infrastructure is common.
In Brazil, for example, over 66% of MRI scanners are more than six years old, while demand for MRI exams is growing rapidly, estimated at 30,000 scans per million inhabitants per year. As patient volumes rise, public institutions often face long wait times, and many providers are challenged to meet demand with outdated equipment.
Health Technology Insights: FlyteHealth Obesity Program Shows Cost Savings, Med Adherence
SubtleHD helps imaging providers unlock new scan slots without purchasing new hardware, improving operational efficiency and patient throughput. With SubtleHD, healthcare institutions in Chile can now benefit from:
- Improved image quality even on older MRI systems
- Faster exam times, helping reduce patient backlog
- Vendor-neutral compatibility with existing infrastructure
“We’re thrilled to expand access to SubtleHD in Chile,” said Josh Gurewitz, Chief Commercial Officer, at Subtle Medical. “With the support of Hospiline, imaging providers across the region can now harness AI to overcome infrastructure gaps, boost productivity, and elevate diagnostic confidence.”
Health Technology Insights: Radicle Science Appoints Liya Sharif Lancia as CMO
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – PR Newswire
